{"id":2425,"date":"2019-11-05T12:33:51","date_gmt":"2019-11-05T12:33:51","guid":{"rendered":"https:\/\/plaza.umin.ac.jp\/~ACP\/?p=2425"},"modified":"2019-11-05T12:34:41","modified_gmt":"2019-11-05T12:34:41","slug":"%e9%a0%bb%e5%87%ba%e8%aa%9eitc103","status":"publish","type":"post","link":"https:\/\/plaza.umin.ac.jp\/~ACP\/2019\/11\/05\/%e9%a0%bb%e5%87%ba%e8%aa%9eitc103.html","title":{"rendered":"\u983b\u51fa\u8a9eITC103"},"content":{"rendered":"\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
\u62bd\u51fa\u8a9e<\/th>\u51fa\u73fe\u56de\u6570<\/th><\/td>\u62bd\u51fa\u8a9e<\/th>\u51fa\u73fe\u56de\u6570<\/th><\/td>\u62bd\u51fa\u8a9e<\/th>\u51fa\u73fe\u56de\u6570<\/th>\n<\/tr>\n<\/thead>\n
failure<\/td>236<\/td><\/td>clinician<\/td>16<\/td><\/td>obesity<\/td>9<\/td>\n<\/tr>\n
heart<\/td>217<\/td><\/td>function<\/td>16<\/td><\/td>activity<\/td>8<\/td>\n<\/tr>\n
patient<\/td>145<\/td><\/td>infarction<\/td>16<\/td><\/td>advanced<\/td>8<\/td>\n<\/tr>\n
risk<\/td>53<\/td><\/td>american<\/td>15<\/td><\/td>adverse<\/td>8<\/td>\n<\/tr>\n
disease<\/td>49<\/td><\/td>arb<\/td>15<\/td><\/td>atrial<\/td>8<\/td>\n<\/tr>\n
ventricular<\/td>42<\/td><\/td>blood<\/td>15<\/td><\/td>current<\/td>8<\/td>\n<\/tr>\n
mortality<\/td>41<\/td><\/td>cardiovascular<\/td>15<\/td><\/td>drug<\/td>8<\/td>\n<\/tr>\n
-rsb-_NN<\/td>39<\/td><\/td>hypertension<\/td>15<\/td><\/td>evaluation<\/td>8<\/td>\n<\/tr>\n
therapy<\/td>39<\/td><\/td>severe<\/td>15<\/td><\/td>higher<\/td>8<\/td>\n<\/tr>\n
inhibitor<\/td>35<\/td><\/td>they<\/td>15<\/td><\/td>hydralazine<\/td>8<\/td>\n<\/tr>\n
not<\/td>35<\/td><\/td>\u00e0-blocker<\/td>14<\/td><\/td>important<\/td>8<\/td>\n<\/tr>\n
you<\/td>34<\/td><\/td>weight<\/td>14<\/td><\/td>mild<\/td>8<\/td>\n<\/tr>\n
symptom<\/td>33<\/td><\/td>chronic<\/td>13<\/td><\/td>morbidity<\/td>8<\/td>\n<\/tr>\n
trial<\/td>33<\/td><\/td>circulation<\/td>13<\/td><\/td>more<\/td>8<\/td>\n<\/tr>\n
ejection<\/td>30<\/td><\/td>diabetes<\/td>13<\/td><\/td>placebo<\/td>8<\/td>\n<\/tr>\n
fraction<\/td>30<\/td><\/td>digoxin<\/td>13<\/td><\/td>primary<\/td>8<\/td>\n<\/tr>\n
myocardial<\/td>28<\/td><\/td>management<\/td>13<\/td><\/td>pulmonary<\/td>8<\/td>\n<\/tr>\n
investigator<\/td>27<\/td><\/td>significant<\/td>13<\/td><\/td>addition<\/td>7<\/td>\n<\/tr>\n
it<\/td>27<\/td><\/td>survival<\/td>13<\/td><\/td>all-cause<\/td>7<\/td>\n<\/tr>\n
other<\/td>27<\/td><\/td>diuretic<\/td>12<\/td><\/td>asymptomatic<\/td>7<\/td>\n<\/tr>\n
who<\/td>27<\/td><\/td>dose<\/td>12<\/td><\/td>benefit<\/td>7<\/td>\n<\/tr>\n
clinical<\/td>26<\/td><\/td>exercise<\/td>12<\/td><\/td>change<\/td>7<\/td>\n<\/tr>\n
coronary<\/td>26<\/td><\/td>more<\/td>12<\/td><\/td>congestive<\/td>7<\/td>\n<\/tr>\n
dysfunction<\/td>26<\/td><\/td>physical<\/td>12<\/td><\/td>controlled<\/td>7<\/td>\n<\/tr>\n
cardiac<\/td>25<\/td><\/td>which<\/td>12<\/td><\/td>day<\/td>7<\/td>\n<\/tr>\n
factor<\/td>25<\/td><\/td>diastolic<\/td>11<\/td><\/td>disorder<\/td>7<\/td>\n<\/tr>\n
hospitalization<\/td>25<\/td><\/td>functional<\/td>11<\/td><\/td>enalapril<\/td>7<\/td>\n<\/tr>\n
artery<\/td>24<\/td><\/td>history<\/td>11<\/td><\/td>even<\/td>7<\/td>\n<\/tr>\n
effect<\/td>23<\/td><\/td>natriuretic<\/td>11<\/td><\/td>f<\/td>7<\/td>\n<\/tr>\n
that<\/td>23<\/td><\/td>test<\/td>11<\/td><\/td>greater<\/td>7<\/td>\n<\/tr>\n
also<\/td>22<\/td><\/td>condition<\/td>10<\/td><\/td>however<\/td>7<\/td>\n<\/tr>\n
systolic<\/td>22<\/td><\/td>control<\/td>10<\/td><\/td>hypertrophy<\/td>7<\/td>\n<\/tr>\n
guideline<\/td>21<\/td><\/td>diagnosis<\/td>10<\/td><\/td>information<\/td>7<\/td>\n<\/tr>\n
less<\/td>21<\/td><\/td>implantation<\/td>10<\/td><\/td>j.jacc<\/td>7<\/td>\n<\/tr>\n
level<\/td>21<\/td><\/td>large<\/td>10<\/td><\/td>many<\/td>7<\/td>\n<\/tr>\n
pressure<\/td>21<\/td><\/td>peptide<\/td>10<\/td><\/td>population<\/td>7<\/td>\n<\/tr>\n
class<\/td>20<\/td><\/td>renal<\/td>10<\/td><\/td>prevention<\/td>7<\/td>\n<\/tr>\n
such<\/td>20<\/td><\/td>significantly<\/td>10<\/td><\/td>quality<\/td>7<\/td>\n<\/tr>\n
what<\/td>20<\/td><\/td>specific<\/td>10<\/td><\/td>reduction<\/td>7<\/td>\n<\/tr>\n
cardiomyopathy<\/td>19<\/td><\/td>standard<\/td>10<\/td><\/td>result<\/td>7<\/td>\n<\/tr>\n
study<\/td>19<\/td><\/td>symptomatic<\/td>10<\/td><\/td>sign<\/td>7<\/td>\n<\/tr>\n
treatment<\/td>19<\/td><\/td>abnormality<\/td>9<\/td><\/td>sinus<\/td>7<\/td>\n<\/tr>\n
I<\/td>18<\/td><\/td>agent<\/td>9<\/td><\/td>smoking<\/td>7<\/td>\n<\/tr>\n
rate<\/td>18<\/td><\/td>decompensated<\/td>9<\/td><\/td>status<\/td>7<\/td>\n<\/tr>\n
death<\/td>17<\/td><\/td>evidence<\/td>9<\/td><\/td>support<\/td>7<\/td>\n<\/tr>\n
outcome<\/td>17<\/td><\/td>group<\/td>9<\/td><\/td>systemic<\/td>7<\/td>\n<\/tr>\n
when<\/td>17<\/td><\/td>high<\/td>9<\/td><\/td>volume<\/td>7<\/td>\n<\/tr>\n
acute<\/td>16<\/td><\/td>left<\/td>9<\/td><\/td>ace<\/td>6<\/td>\n<\/tr>\n
care<\/td>16<\/td><\/td>lower<\/td>9<\/td><\/td>blocker<\/td>6<\/td>\n<\/tr>\n
cause<\/td>16<\/td><\/td>medical<\/td>9<\/td><\/td>combination<\/td>6<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-2425","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t